These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19625611)
21. GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway. Ying Y; Zhu H; Liang Z; Ma X; Li S J Mol Endocrinol; 2015 Dec; 55(3):245-62. PubMed ID: 26386043 [TBL] [Abstract][Full Text] [Related]
22. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation. Tanner MA; Thomas TP; Grisanti LA J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246 [TBL] [Abstract][Full Text] [Related]
23. Modulation of Fatty Acid-Related Genes in the Response of H9c2 Cardiac Cells to Palmitate and n-3 Polyunsaturated Fatty Acids. Cetrullo S; D'Adamo S; Panichi V; Borzì RM; Pignatti C; Flamigni F Cells; 2020 Feb; 9(3):. PubMed ID: 32110930 [TBL] [Abstract][Full Text] [Related]
24. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion. Zhang Y; Yan H; Guang GC; Deng ZR Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886 [TBL] [Abstract][Full Text] [Related]
25. Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Ku PM; Chen LJ; Liang JR; Cheng KC; Li YX; Cheng JT Cardiovasc Diabetol; 2011 Jun; 10():57. PubMed ID: 21702924 [TBL] [Abstract][Full Text] [Related]
26. Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts. Feng CC; Pandey S; Lin CY; Shen CY; Chang RL; Chang TT; Chen RJ; Viswanadha VP; Lin YM; Huang CY Biomed Pharmacother; 2018 Jan; 97():880-885. PubMed ID: 29136764 [TBL] [Abstract][Full Text] [Related]
27. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects. Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817 [TBL] [Abstract][Full Text] [Related]
29. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells. Liu BC; Chen L; Sun J; Huang HQ; Ma KL; Liu H; Liu DG; Zhang XL Nephron Exp Nephrol; 2006; 103(1):e16-26. PubMed ID: 16374037 [TBL] [Abstract][Full Text] [Related]
30. Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes. Wang X; McLennan SV; Allen TJ; Twigg SM J Cell Commun Signal; 2010 Mar; 4(1):15-23. PubMed ID: 20195389 [TBL] [Abstract][Full Text] [Related]
31. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209 [TBL] [Abstract][Full Text] [Related]
33. Puerarin attenuates pressure overload-induced cardiac hypertrophy. Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530 [TBL] [Abstract][Full Text] [Related]
34. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. He Z; Way KJ; Arikawa E; Chou E; Opland DM; Clermont A; Isshiki K; Ma RC; Scott JA; Schoen FJ; Feener EP; King GL J Biol Chem; 2005 Apr; 280(16):15719-26. PubMed ID: 15699040 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of Notch1 signaling activation against high glucose-induced myocardial cell injury: Analysis of its mechanisms of action. Zhang J; Li B; Zheng Z; Kang T; Zeng M; Liu Y; Xia B Int J Mol Med; 2015 Sep; 36(3):897-903. PubMed ID: 26202569 [TBL] [Abstract][Full Text] [Related]
37. NAKα2 inhibits fibrosis formation and protects against cardiomyocyte hypertrophy by suppressing hypertrophy associated molecules and activating LTCC/NCX signaling pathway. Song SS; Tang G; Tang LX; Si LY; Xiong W Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3021-3033. PubMed ID: 31002153 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy. Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837 [TBL] [Abstract][Full Text] [Related]
39. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Wang M; Zhang WB; Zhu JH; Fu GS; Zhou BQ Acta Pharmacol Sin; 2009 Aug; 30(8):1081-91. PubMed ID: 19597526 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms. Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]